glp 1 and alzheimer's study Details of failed studies cast pall on Novo Nordisk's GLP-1 as treatment Disappointing GLP-1 Results in Alzheimer's

Why GLP1s Are Gaining Attention in Liver Disease GLP1 receptor agonists, including semaglutide and other analogs, exert multiple metabolic effects: they enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and promote weight loss

After adjusting for age, gender, body mass index, MELD, etiology of cirrhosis, and TIPS indications, Native Americans had increased odds of 30-day post-TIPS mortality (adjusted OR 2.8

Npj Digit Med

Other GLP-1 medications prescribed for type 2 diabetes also support weight loss (albeit not as effectively as these two)

When illness further suppresses your desire or ability to eat and drink, you may need to pause treatment